The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
Abstract
OBJECTIVE: To update the 1997 clinical practice guidelines for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast and colorectal cancers. These guidelines are intended for use in the care of patients outside of clinical trials. OPTIONS: Six tumor markers for colorectal cancer and eight for breast cancer were considered. They could be recommended or not for routine use or for special circumstances. In addition to carcinoembryonic antigen (CEA) and CA 15-3, CA 27.29 was also considered among the serum tumor markers for breast cancer. OUTCOMES: In general, the significant health outcomes identified for use in making clinical practice guidelines (overall survival, disease-free survival, quality of life, lesser toxicity, and cost-effectiveness) were used. EVIDENCE: A computerized literature search from 1994 to March 1999 was performed. VALUES: The same values for use, utility, and levels of evidence were used by the committee. BENEFITS, HARMS, AND COSTS: The same benefit, harms, and costs were used. RECOMMENDATION: Changes were recommended (see Appendix). VALIDATION: The updated recommendations were validated by external review by the American Society of Clinical Oncology’s (ASCO’s) Health Services Research Committee and by ASCO’s Board of Directors. SPONSOR: American Society of Clinical Oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Pegram, M. D., Lipton, A., Hayes, D. F., Weber, B. L., Baselga, J. M., Tripathy, D., Baly, D., Baughman, S. A., Twaddell, T., Glaspy, J. A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2659 · Cited by 1,067
Self-citationc-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301802 · Cited by 961
Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., Säve-Söderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., & Reed, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1049 · Cited by 838
Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2894 · Cited by 802
Allred, D. C., Clark, G. M., Elledge, R., Fuqua, S. A. W., Brown, R. W., Chamness, G. C., Osborne, C. K., & McGuire, W. L. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.3.200 · Cited by 772
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Self-citationMigliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 626
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer
Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1346 · Cited by 612
Paik, S., Hazan, R., Fisher, E. R., Sass, R. E., Fisher, B., Redmond, C., Schlessinger, J., Lippman, M. E., & King, C. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.1.103 · Cited by 594
HER-2/neu oncogene protein and prognosis in breast cancer.
Tandon, A. K., Clark, G. M., Chamness, G. C., Ullrich, A., & McGuire, W. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1120 · Cited by 574
Seshadri, R., Firgaira, F. A., Horsfall, D. J., McCaul, K., Setlur, V, & Kitchen, P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1936 · Cited by 528
Allred, D. C., Clark, G. M., Tandon, A. K., Molina, R., Tormey, D. C., Osborne, C. K., Gilchrist, K. W., Mansour, E. G., Abeloff, M., & Eudey, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.599 · Cited by 456
Andrulis, I. L., Bull, S. B., Blackstein, M. E., Sutherland, D., Mak, C., Sidlofsky, S., Pritzker, K. P., Hartwick, R. W., Hanna, W., Lickley, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1340 · Cited by 441
Pietras, R. J., FENDLY, B. M., Chazin, V. R., Pegram, M. D., Howell, S. B., & Slamon, D. J. (1994) · PubMed · Cited by 437
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 431
Carlomagno, C., Perrone, F., Gallo, C., De Laurentiis, M., Lauria, R., Morabito, A., Pettinato, G., Panico, L., D'Antonio, A., Bianco, A. R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2702 · Cited by 407
Slamon, D. J. (1998) · Medical Entomology and Zoology · Cited by 347
Kallioniemi, O., Holli, K., Visakorpi, T., Koivula, T., Helin, H. H., & Isola, J. J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490504 · Cited by 346
Ahnen, D. J., Feigl, P., Quan, G., Fenoglio‐Preiser, C. M., Lovato, L., Bunn, P. A., Stemmerman, G. N., Wells, J. D., Macdonald, J. S., & Meyskens, F. L. (1998) · PubMed · Cited by 338
Paterson, M. C., Dietrich, K. D., Danyluk, J., Paterson, A. H., LEES, A. W., Jamil, N. S. M., Hanson, J., Jenkins, H., Krause, B. E., & McBlain, W. A. (1991) · PubMed · Cited by 296
Follow-up study of HER-2/neu amplification in primary breast cancer.
Clark, G. M., & McGuire, W. L. (1991) · PubMed · Cited by 261
Rilke, F., Colnaghi, M. I., Cascinelli, N., Andreola, S., Baldini, M. T., Bufalino, R., Porta, G. D., Ménard, S., Pierotti, M. A., & Testori, A. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490109 · Cited by 259
Yamauchi, H., O'Neill, A., Gelman, R., Carney, W., Tenney, D. Y., Hösch, S., & Hayes, D. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2518 · Cited by 239
Self-citationBautista, S., Valles, H., Walker, R. L., Anzick, S. L., Zeillinger, R., Meltzer, P. S., & Theillet, C. G. (1998) · PubMed · Cited by 231
Houston, S. J., Plunkett, T. A., Barnes, D. M., Smith, P., Rubens, R. D., & Miles, D. W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690196 · Cited by 220
Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Lapidus, R. G., Nass, S. J., Butash, K. A., Parl, F. F., Weitzman, S. A., Graff, J. R., Herman, J. G., & Davidson, N. E. (1998) · PubMed · Cited by 206
Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical Oncology
Desch, C. E., Benson, A. B., Smith, T. J., Flynn, P. J., Krause, C., Loprinzi, C. L., Minsky, B. D., Petrelli, N. J., Pfister, D. G., & Somerfield, M. R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1312 · Cited by 193
Self-citationNewby, J. C., Johnston, S. R. D., Smith, I. E., et al. (1997) · PubMed · Cited by 192
Giangrande, P. H., Pollio, G., & McDonnell, D. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32889 · Cited by 186
Hayes, D. F., Trock, B., & Harris, A. L. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006197805041 · Cited by 184
Self-citationGraham, R. A., Wang, S., Catalano, P. J., & Haller, D. G. (1998) · Annals of Surgery · doi:10.1097/00000658-199807000-00009 · Cited by 176
Clahsen, P. C., van de Velde, C. J., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van den Broek, L., Sahmoud, T. M., & van de Vijver, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.470 · Cited by 171
HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications.
Baselga, J. M., Seidman, A. D., Rosen, P. P., & Norton, L. (1997) · PubMed · Cited by 157
Kumar, R., Mandal, M., Lipton, A., Harvey, H. A., & Thompson, C. B. (1996) · PubMed · Cited by 144
Rosen, P. P., LESSER, M. L., Arroyo, C. D., Cranor, M. L., Borgen, P. I., & Norton, L. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.821 · Cited by 131
Yu, D., Liu, B., Jing, T., Sun, D., Price, J. E., Singletary, S. E., Ibrahim, N., Hortobágyi, G. N., & Hung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201729 · Cited by 127
Value of postoperative surveillance after radical surgery for colorectal cancer
Castells, A., Bessa, X., Daniels, M., Ascaso, C., Lacy, A. M., García‐Valdecasas, J. C., Gargallo, L., Novell, F., Astudillo, E., Filella, X., et al. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236257 · Cited by 108
Bevilacqua, P., Barbareschi, M., Verderio, P., Boracchi, P., Caffo, O., Palma, P., Meli, S., Weidner, N., & Gasparini, G. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666041 · Cited by 105
Giai, M., Roagna, R., Ponzone, R., Bortoli, M. D., Dati, C., & Sismondi, P. (1994) · PubMed · Cited by 89
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
Gion, M., Mione, R., Leon, A. E., & Dittadi, R. (1999) · PubMed · Cited by 87
The pathophysiological role of estrogen receptor variants in human breast cancer
Murphy, L. C., Dotzlaw, H., Leygue, E., Coutts, A. S., & Watson, P. H. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00012-0 · Cited by 58
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors
Richer, J. K., Lange, C. A., Wierman, A., Brooks, K. M., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005941117247 · Cited by 53
Iacopetta, B. J., Grieu, F., Powell, B. L., et al. (1998) · PubMed · Cited by 53
Torregrosa, D., Bolufer, P., Lluch, A. M., López, J. A., Barragán, E., Ruíz, A., Guillém, V., Munárriz, B., & Conde, J. G. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06542-x · Cited by 46
Ciocca, D. R., Green, S., Elledge, R. M., Clark, G. M., Pugh, R., Ravdin, P., Lew, D., Martino, S., & Osborne, C. K. (1998) · PubMed · Cited by 45
Self-citationCharpin, C., Garcia, S., Bouvier, C., Martini, F., Lavaut, M.-N., Allasia, C., Bonnier, P., & Andrac, L. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.283 · Cited by 36
Russo, A. D., Migliavacca, M., Bazan, V., Maturi, N., Morello, V., Dardanoni, G., Modica, G., Bazan, P., Albanese, I., Farina, M. L., et al. (1998) · Cell Proliferation · doi:10.1046/j.1365-2184.1998.00116.x · Cited by 32
An, H., Niederacher, D., Beckmann, M. W., Göhring, U.-J., Scharl, A. J., Picard, F., van Roeyen, C. R. C., Schnürch, H.-G., & Bender, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640502 · Cited by 30
Knowlden, J. M., Gee, J. M. W., Bryant, S., McClelland, R. A., Manning, D. L., Mansel, R. E., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., & Nicholson, R. I. (1997) · PubMed · Cited by 30
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer
Devine, P. L., Duroux, M., Quin, R. J., McGuckin, M. A., Joy, G. J., Ward, B. G., & Pollard, C. W. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00689716 · Cited by 29
Review of Clinical Studies of CA 27.29 in Breast Cancer Management
Beveridge, R. A. (1999) · The International Journal of Biological Markers · doi:10.1177/172460089901400107 · Cited by 20
Baretton, G. B., Vogt, M., Müller, C., Diebold, J., Schneiderbanger, K., Schmidt, M., & Löhrs, U. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609006769 · Cited by 18
Žaloudík, J., Vagunda, V., Drahokoupilová, M., Janáková, L., Talač, R., Kalabis, J., & Sheard, M. A. (1997) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(97)00081-7 · Cited by 9
Cited by
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Self-citationPaik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Self-citation
Metadata
- Authors
- Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-03-15
- Volume
- 19
- Issue
- 6
- Pages
- 1865-1878
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1955382134
- Cited by
- 879
- References
- 57
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.